Pictet & Cie (Europe) Sa Sop Hi A Genetics Sa Transaction History
Pictet & Cie (Europe) Sa
- $4.64 Billion
- Q2 2025
A detailed history of Pictet & Cie (Europe) Sa transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Pictet & Cie (Europe) Sa holds 255,200 shares of SOPH stock, worth $890,648. This represents 0.02% of its overall portfolio holdings.
Number of Shares
255,200
Previous 255,200
-0.0%
Holding current value
$890,648
Previous $847,000
6.61%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding SOPH
# of Institutions
38Shares Held
25.5MCall Options Held
500Put Options Held
3.8K-
Ubs Asset Management Americas Inc Chicago, IL7.63MShares$26.6 Million0.01% of portfolio
-
Generation Investment Management LLP London, X06.79MShares$23.7 Million0.14% of portfolio
-
Chuck Akre Akre Capital Management LLC | Middleburg, Va2.24MShares$7.81 Million0.08% of portfolio
-
Banque Pictet & Cie Sa2.21MShares$7.71 Million0.05% of portfolio
-
Credit Suisse Ag Zurich, V82.17MShares$7.56 Million0.01% of portfolio
About SOPHiA GENETICS SA
- Ticker SOPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 64,153,700
- Market Cap $224M
- Description
- SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...